Zacks Research Issues Negative Outlook for TEVA Earnings
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) – Investment analysts at Zacks Research decreased their Q1 2026 earnings per share (EPS) estimates for Teva Pharmaceutical Industries in a research report issued on Monday, April 28th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $0.47 for the […]
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) – Investment analysts at Zacks Research decreased their Q1 2026 earnings per share (EPS) estimates for Teva Pharmaceutical Industries in a research report issued on Monday, April 28th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $0.47 for the […]
